22 Jul 2021 ADOCIA Announces Second Quarter 2021 Financial Results Icon check
15 Jul 2021 Number of shares and voting rights of ADOCIA as of June 30th, 2021 Icon check
29 Jun 2021 ADOCIA Initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes Icon check
27 Jun 2021 ADO09, a coformulation of insulin A21G and pramlintide (Pram), improves blood glucose control and reduces body weight in subjects with T1D, Dr. Grégory Meiffren, June 27, 2021, ADA virtual event.
15 Jun 2021 ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81st Scientific Sessions Icon check
10 Jun 2021 Number of shares and voting rights of ADOCIA as of May 31st, 2021 Icon check
08 Jun 2021 ADOCIA confirms its eligibility for the PEA–PME Icon check
02 Jun 2021 ADO09, a co-formulation of pramlintide and insulin A21G improves postprandial glucose (PPG) versus insulin Aspart  in type 1 diabetes, Dr.  Grégory Meiffren, June 2, 2021, ATTD, Virtual event.
02 Jun 2021 ADOCIA Presents Clinical Results on M1Pram at the 14th International Conference on ATTD 2021 Icon check
01 Jun 2021 ADOCIA reinforces its board of directors with the appointment of three new independent members. Icon check
26 May 2021 ADOCIA Expands Clinical Development to Obesity with Patent Applications on Short-Acting Multihormonal Combinations Administered by Pumps Icon check
17 May 2021 Number of shares and voting rights of ADOCIA as of April 30, 2021 Icon check
11 May 2021 ADOCIA Announces the Live Broadcast of its Annual General Meeting on May 20th, 2021 Icon check
23 Apr 2021 ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes. Diabetes Obes Metab., 2021;23(4):961-970. Icon check
21 Apr 2021 ADOCIA Announces the Release of its Universal Registration Document for the Year 2020 Icon check
21 Apr 2021 ADOCIA Announces First Quarter 2021 Financial Results Icon check
19 Apr 2021 ADOCIA: Number of shares and voting rights of ADOCIA as of March 31st, 2021 Icon check
18 Mar 2021 ADOCIA Announces Financial Results 2020 And Provides Corporate Update. Icon check
17 Mar 2021 Number of shares and voting rights of ADOCIA as of February 28th, 2021 Icon check
10 Mar 2021 Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes Icon check
16 Feb 2021 Number of shares and voting rights of ADOCIA as of January 31, 2021 Icon check
25 Jan 2021 Adocia Announces Positive Clinical Results Confirming the Ultra-Rapid Profile of a BioChaperone® Lispro Formulation Containing Insulin from Partner Tonghua Dongbao Icon check
20 Jan 2021 Number of shares and voting rights of ADOCIA as of December 31, 2020 Icon check
18 Jan 2021 Adocia Announces half year report on Adocia’s liquidity agreement with Kepler Capital Markets Icon check
11 Jan 2021 Adocia Files Patent on a Hydrogel Scaffold for Cell Therapy in the Treatment of Type 1 Diabetes Icon check
21 Dec 2020 Adocia announces its financial calendar for 2021 Icon check
07 Dec 2020 Number of shares and voting rights of ADOCIA as of November 30, 2020 Icon check
06 Nov 2020 Number of shares and voting rights of ADOCIA as of October 31, 2020 Icon check
20 Oct 2020 Adocia Announces Third Quarter 2020 Financial Results Icon check
09 Oct 2020 Number of shares and voting rights of ADOCIA as of September 30, 2020 Icon check
22 Sep 2020 Adocia announces a Video Conference to Present a Corporate Update Wednesday, September 23rd, 2020 Icon check
15 Sep 2020 Adocia announces Positive Topline Results of Phase 1b Study for M1Pram in People with type 1 Diabetes. Icon check
10 Sep 2020 ADO09, a co-formulation of amylin analog pramlintide and human insulin analog A21G, reduces postprandial blood sugar compared to insulin lispro in type 1 diabetes, Dr.  Grégory Meiffren, September 10, 2020, Société Francophone du Diabète, Virtual Event.
08 Sep 2020 Number of shares and voting rights of ADOCIA as of August 31, 2020 Icon check
07 Sep 2020 September 15th: Adocia to Present at H.C. Wainwright Global Investment Conference (Virtual Event) Icon check
05 Sep 2020 ADO09, A Co-Formulation of the Amylin-Analog Pramlintide and the A21G Human Insulin Analog, Lowers Postprandial Blood Glucose versus Insulin Lispro in Type 1 Diabetes (T1D) presented by Dr. Gregory Meiffren, 2020, ATTD, virtual experience. Icon check
03 Sep 2020 September 10th: Adocia Oral Presentation at the Annual Congress of the Société Francophone du Diabète (SFD). Icon check
25 Aug 2020 Number of shares and voting rights of ADOCIA as of July 31, 2020 Icon check
18 Aug 2020 Adocia was granted a State-guaranteed loan (PGE) for EUR 7 million associated with a rescheduling of the loan terms contracted in 2019. Icon check
30 Jul 2020 Adocia initiates BioChaperone® Lispro comparative study to validate THDB insulin lispro for Phase 3 BC Lispro trials in Europe and U.S Icon check
20 Jul 2020 Adocia Announces First Half 2020 Financial Results Icon check
06 Jul 2020 Number of shares and voting rights of ADOCIA as of June 30, 2020 Icon check
16 Jun 2020 ADO09, a coformulation of pramlintide (PRAM) and insulin A21G, improves postprandial glucose vs. Novolog(R) in Type 1 Diabetes (T1D), Dr. Gregory Meiffren, June 12-16, 2020, ADA virtual experience.
16 Jun 2020 ADO09, a Coformulation of Pramlintide (PRAM) and Insulin A21G, Improves Postprandial Glucose vs. Novolog in Type 1 Diabetes (T1D) (Poster # 2020-LB-7039-Diabetes), presented by Dr. Gregory Meiffren, June 12-16, 2020, ADA virtual experience. Icon check
16 Jun 2020 ADO09, a coformulation of pramlintide (PRAM) and insulin A21G, improves postprandial glucose vs. Novolog(R) in Type 1 Diabetes (T1D), Dr. Gregory Meiffren, June 12-16, 2020, ADA virtual experience.
08 Jun 2020 Adocia Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 80th Scientific Sessions – Virtual experience Icon check
05 Jun 2020 Number of shares and voting rights of ADOCIA as of May 31, 2020 Icon check
03 Jun 2020 ADO09, A Co-Formulation of the Amylin-Analog Pramlintide and the A21G Human Insulin Analog, Lowers Postprandial Blood Glucose versus Insulin Lispro in Type 1 Diabetes (T1D) presented by Dr. Gregory Meiffren, 2020, ATTD, virtual experience. Icon check
11 May 2020 Number of shares and voting rights of ADOCIA as of April 30, 2020 Icon check
23 Apr 2020 Adocia announces positive topline results of the exploratory Phase 1b study of ADO09 (M1Pram) in people with type 1 diabetes Icon check
Join our mailing list. Subscribe